ENZ - ENZO BIOCHEM INC
0.3138
-0.068 -21.606%
Share volume: 4,123,861
Last Updated: 04-17-2025
Healthcare/Services – Health:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$0.38
-0.07
-0.18%
View ratios
| Fiscal Date | 10-31-2023 | 01-31-2024 | 04-30-2024 | 07-31-2024 | 10-31-2024 | 01-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 12-16-2024 | 03-13-2024 | 06-13-2024 | 12-16-2024 | 12-16-2024 | 03-17-2025 | |
| Assets | |||||||
| Total Assets | 106.308 M | 99.077 M | 93.469 M | 85.764 M | 75.291 M | 67.510 M | |
| Current Assets | 88.012 M | 80.920 M | 75.736 M | 70.031 M | 59.661 M | 52.217 M | |
| Inventories | 7.595 M | 7.800 M | 7.324 M | 6.832 M | 6.391 M | 5.987 M | |
| Other Current Assets | 0.000 | 7.763 M | 0.000 | 5.000 M | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 7.763 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 5.116 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 69.207 M | 60.241 M | 57.156 M | 52.371 M | 47.735 M | 40.297 M | |
| Total Non-current Assets | 0.000 | 18.157 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 13.075 M | 12.837 M | 12.638 M | 12.367 M | 12.495 M | 12.303 M | |
| Other Assets | 5.221 M | 645.000 K | 5.095 M | 3.366 M | 3.135 M | 2.990 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 106.308 M | 99.077 M | 93.469 M | 85.764 M | 75.291 M | 67.510 M | |
| Total liabilities | 32.033 M | 28.302 M | 24.438 M | 29.652 M | 27.633 M | 20.894 M | |
| Total current liabilities | 28.842 M | 25.283 M | 21.663 M | 24.794 M | 23.397 M | 17.176 M | |
| Accounts Payable | 1.962 M | 1.318 M | 1.520 M | 1.376 M | 1.269 M | 672.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 3.225 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 219.000 K | 234.000 K | 180.000 K | 189.000 K | 155.000 K | 146.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 74.275 M | 70.775 M | 69.031 M | 56.112 M | 47.658 M | 46.616 M | |
| Common stock | 346.495 M | 50.490 M | 347.580 M | 348.655 M | 343.502 M | 343.682 M | |
| Retained earnings | -274.966 M | -278.027 M | -281.047 M | -294.428 M | -297.804 M | -299.339 M |